Cited by 183Bariatric Surgery and OutcomesPancreatic function and diabetesMinimally Invasive Surgical Techniques

Reversible Hyperinsulinemic Hypoglycemia after Gastric Bypass: A Consequence of Altered Nutrient Delivery

McLaughlin, Tracey, Peck, Marcia, Holst, Jens, Deacon, Carolyn·2010·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of beta-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute. Objective The objective of this study was to elucidate the pathophysiology of this condition; specifically, we hypothesized that metabolic abnormalities were a function of altered nutrient transit through the gastrointestinal tract rather than anatomical changes to pancreatic beta-cells that would lead to consistently high insulin secretion irrespective of nutrient transit route. DESIGN/SETTING/SUBJECT/OUTCOME MEASURES: We describe a unique case wherein gastrostomy tube (GT) insertion into the remnant stomach reversed neuroglycopenic symptoms. This subject was admitted to a university hospital research center for standardized measurement of glucose, insulin, and incretin hormones including glucagon-like peptide-1, gastric-inhibitory peptide, and glucagon. Results Standardized liquid meal administration via GT vs. oral route demonstrated complete reversal of severe metabolic abnormalities that included hypersecretion of insulin and GLP-1. Conclusion Post-RYGB hyperinsulinemia and hypoglycemia result entirely from alte…

Integrity signals

Registry

Crossref · 10.1210/jc.2009-1628

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Restoring the original nutrient transit route via placement of a gastric tube in the remnant stomach was also reported to be effective.

    “Restoring the original nutrient transit route via placement of a gastric tube in the remnant stomach was also reported to be effective (127).”
  • Standardized liquid meal administration via a gastric tube demonstrated complete reversal of severe metabolic abnormalities including hypersecretion of insulin and incretin hormones such as GLP-1 compared with oral administration.

    “Standardized liquid meal administration via a gastric tube demonstrated complete reversal of severe metabolic abnormalities including hypersecretion of insulin and incretin hormones such as GLP-1 compared with oral administration (127).”
  • Enteral nutrition via gastrostomy tube placement in the remnant pouch reduced hypoglycemic symptoms in RYGB case reports.

    “In the case of RYGB, case reports have demonstrated that enteral nutrition via gastrostomy tube placement in the remnant pouch reduced hypoglycemic symptoms [68,69].”

The citation lists haven’t been fetched yet

References 25 · Cited by 183

Authors
McLaughlin, T., Peck, M., Holst, J., & Deacon, C.
Affiliations
  • Stanford Medicine (US)
  • University of Copenhagen (DK)
Corresponding author
McLaughlin, Tracey
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-04-01
Volume
95
Issue
4
Pages
1851-1855
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2138474841
Cited by
183
References
25
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 8 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 13 · 2017: 15 · 2016: 18 · 2015: 16 · 2014: 14 · 2013: 18 · 2012: 15
FWCI
20.43
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
Keywords
Roux-en-Y gastric bypass, postprandial hypoglycemia, hyperinsulinemia, neuroglycopenia, gastrostomy tube, incretins, glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, glucagon, nesidioblastosis, morbid obesity, bariatric surgery complications
MeSH terms
Adult, Blood Glucose, Female, Gastric Inhibitory Polypeptide, Glucagon, Humans, Hyperinsulinism, Hypoglycemia, Insulin, Nutritional Status, Obesity, Morbid, Postoperative Complications, Gastric Bypass, Body Mass Index, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review